GSK tech is wasting money and necessitating layoffs elsewhere

^^ This!! It's like being a passenger on a slow motion train wreck. We should bring in that hotshot Lucra Technology Group to show us how it's done right.

 

Nicely done.. Bring in the former help at 5x the cost via a consulting gig.

 

Sound in line with how KAT run things Let someone with no engineering experience lead the company on a vital data thing showsup video about how great Code Orange is. Then hire expensive consultants to double check the work being done, because she can't tell what's real and what's not herself, but can spend money for other people to tell her. I think this being done right now

 

KAT found a replacement for The Letter J - leaving the same role he had at Eli Lilly. A role he held for less than a year, interestingly enough.

 

Wow! I knew IT had issues but watching this thread from afar is really making me wonder whats going on over there.

 

Anyone seen this font? Or maybe a video about the font?

 

Recent pigeonhole survey and vote sessions were pretty entertaining although nothing like K@t's disaster town hall last year. Someone's going to have to spit blood and eat fire to top that performance.

 

It's sad that trust at GSK is so low (as shown by the survey) that employees come here to gripe about legitimate concerns, knowing full well they have no real voice, and no reason to think anything can be changed. There are 10000 views of this thread, that says something, too. Meanwhile, awful leaders continue to carry on like they are rockstars, spending money frivolously, demonstrating no real value (who would judge value anyway in tech, KAT?), with zero accountability or motivation to do the right thing. Egos on the rise, always!

 

Perfectly stated. GSK/Viiv is in the throes of terminal denial. Most leadership emails are severely detached from reality to the point that one is forced to ask if Peyote is mandatory for those at the top. There is not an iota of common sense and they are not really listening to anybody. Mostly because the only warm cozy place of refuge they can find is within the bowels of their collective echo chambers.
Viiv is going to be seeing major restructuring and many job cuts. The next few weeks will be a jizzfest of euphemistic emails talking about how a learner structure is the forward vision for the company and how it was always how it was meant to be. I suspect GSK is doing the same.
I want each of you endowed with a functioning nervous system to understand what your options are, where you stand in the line of fire and be able to make decisions that protect you and your family from economic annihilation. Help those you can, more importantly help yourself first. Dovato sales are probably panic inducing because they hoped that it would be blockbuster. It did become just that, but without the buster part.
Peace and be safe.

 

Hard to deny what the last post has written. Honest question to you..So if Trelegy and Anoro only generate pennies on the dollar in profit, Shingrix has been maxed out, Nucala is dead man walking, and now you are claiming that Dovato has failed after only a month into launch, what is the future of the company? Many have speculated based on cryptic euphemisms delivered by GSK leadership. Selling off the respiratory and consumer divisions with a focus on "specialty" products? We are already hearing of "silent layoffs". Will GSK merge? Will we be sold off in in pieces? Will Tesaro be able to save the company? This is what I see...Respiratory will be downsized drastically and will become a specialty division. Vaccines & ViiV will also see small cuts to their teams. GSK will become a lean specialty company. This will happen at some point next year. Tesaro / Oncology is already in the process of ramping up. ViiV has a launch sometime in the next 6 to 12 months. The company will make cuts and reorg in order to expedite this new focus. No one is safe. Not reps. Not FLLs. Not SVPs nor Directors. Very little shuffling between divisions. If you are under the age of 50, you should be looking..I am. Folks, I am giving you the truth. Deny all you want but it's all been decided..over a year ago. Just trying to help.

 

Can you please elaborate about Shingrix being maxed out??

 

I don't understand how Kat gets away with it. Doesn't Emma look at the survey? If I were her, I would wonder why the person I brought in to "transform" in digital and tech has such low scores even from within her own organization around digital and tech giving GSK a competitive advantage. Those survey scores are evidence of a very dysfunctional organisation. It almost seems like abuse. Leaders from the top should be accountable for what they are enabling and stop blaming bad survey results on the transformation and telling people they need to make things better themselves. Just stop disrespecting people and maybe results will improve.

 

Because she's a woman who was hired by a woman.

 

Because Kat’s in the Cradle with a silver spoon!

 

Being a woman has nothing to do with her competency. Unfortunately, she just isn't competent. The problem is pharma seems to not understand tech, so if your senior most tech leader is incompetent, no one on the business side knows tech enough to call it out. Surveys, lack of delivery, suspicious and expensive hires and contracts, these should all be warning signs, but I guess that's how disconnected pharma is from reality. The pricing of drugs should make that obvious, I guess.

 

So how do people feel about Agam aka the new J

 

Api Vista

 

This is an anonymous gossip site. Who comes here for credible conversation? You silly Brits. You take your royalty seriously, too, right?

 

More layoffs are being announced next week